Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer. Its end-to-end technology platform is built on multiple proprietary exclusive product development and product enhancement technologies, and allows Medigene to create best-in-class differentiated, T cell receptor engineered T cell (TCR-T) therapies for multiple solid tumor indications that are optimized for both safety and efficacy. This platform provides product candidates for both its in-house therapeutics pipeline and partnering.
For more information, please visit www.medigene.com
Company Details
- Employees
- 88
- Founded
- -
- Phone
- +49-89-20 00 33 - 29 20
- me****@****ene.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- medigene.com
Medigene Ag Questions
Medigene Ag's helpline number is +49-89-20 00 33 - 29 20
Medigene Ag's website is medigene.com
Medigene Ag's LinkedIn profile is https://www.linkedin.com/company/medigene-ag
Medigene Ag has
88 employees.
View email and phone details for 88
employees at Medigene Ag.
Medigene Ag's industry is
Biotechnology Research
Medigene Ag's top competitors are
Ethris,
Curevac,
Iomx Therapeutics Ag,
Tubulis Gmbh,
Eisbach Bio Gmbh,
Formycon Ag,
Morphosys,
Immatics,
Biontech Se,
Proteros Biostructures Gmbh.
Medigene Ag's support email address is medigene@medigene.com
Medigene Ag's categories are Biotechnology Research
Medigene Ag's founding year is 1994
